{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T14:05:19Z","timestamp":1767276319638,"version":"3.41.2"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Autosomal dominant osteopetrosis II (ADO II, MIM166600) is a sclerosing bone disorder caused by <jats:italic>CLCN7<\/jats:italic> mutation. The main clinical characteristics include minor trauma-related fracture and hip osteoarthritis, whereas cranial nerve palsy and bone marrow failure rarely develop. Although it is generally believed that ADO II has a relatively benign course, the natural course of the disease in Chinese patients remains unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>Thirty-six patients diagnosed with ADO II in Shanghai Jiao Tong University Affiliated Sixth People\u2019s Hospital from 2008 to 2021 were studied retrospectively. Among them, 15 patients were followed for an average of 6.3 years (1-14 years).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In this study, minor trauma-related fractures of the limb were the most typical clinical manifestations. Visual loss (1\/36) and bone marrow failure (2\/36), was rare in this study. The condition of ADO II seems to be stable in most patients. There were no correlations between markedly elevated bone mineral density (BMD) and minor trauma-related fractures. In total, 21 diseases causing mutations were detected. Among them, the mutation c.2299C&amp;gt;T (p.Arg767Trp) was the most common (16.67%), and mutation c.937G&amp;gt;A [p.(Glu313Lys)] was associated with severe fractures, haematological defects and cranial palsy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Minor trauma-related fracture is the most typical clinical manifestation of ADO II and always occurs in. The mutation c.2299C&amp;gt;T (p.Arg767Trp) is in general a relatively common variant, while the mutation c.937G&amp;gt;A [p.(Glu313Lys)] seems to be associated with severe phenotype. In our study, ADO II seems to remain stable over time.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.819641","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T13:19:18Z","timestamp":1647523158000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Natural History of Type II Autosomal Dominant Osteopetrosis: A Single Center Retrospective Study"],"prefix":"10.3389","volume":"13","author":[{"given":"Ziyuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenzhen","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(01)00206-9","article-title":"Loss of the Clc-7 Chloride Channel Leads to Osteopetrosis in Mice and Man","volume":"104","author":"Kornak","year":"2001","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra040952","article-title":"Osteopetrosis","volume":"351","author":"Tolar","year":"2004","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1530\/eje-13-0136","article-title":"Autosomal Dominant Osteopetrosis Revisited: Lessons From Recent Studies","volume":"169","author":"Bollerslev","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1210\/edrv-10-1-45","article-title":"Autosomal Dominant Osteopetrosis: Bone Metabolism and Epidemiological, Clinical, and Hormonal Aspects","volume":"10","author":"Bollerslev","year":"1989","journal-title":"Endocr Rev"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.164.1.3588909","article-title":"Heterogeneity of Autosomal Dominant Osteopetrosis","volume":"164","author":"Andersen","year":"1987","journal-title":"Radiology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1750-1172-4-5","article-title":"Osteopetrosis","volume":"4","author":"Stark","year":"2009","journal-title":"Orphanet J Rare Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2013.06.014","article-title":"Identification of Two Novel Clcn7 Gene Mutations in Three Chinese Families With Autosomal Dominant Osteopetrosis Type Ii","volume":"81","author":"Zheng","year":"2014","journal-title":"Joint Bone Spine"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-011-0319-z","article-title":"The Virulence Gene and Clinical Phenotypes of Osteopetrosis in the Chinese Population: Six Novel Mutations of the Clcn7 Gene in Twelve Osteopetrosis Families","volume":"30","author":"Wang","year":"2012","journal-title":"J Bone Miner Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-015-0682-2","article-title":"Two Novel Mutations of Clcn7 Gene in Chinese Families With Autosomal Dominant Osteopetrosis (Type Ii)","volume":"34","author":"Zheng","year":"2016","journal-title":"J Bone Miner Metab"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2019.10123","article-title":"Novel Clcn7 Mutations Cause Autosomal Dominant Osteopetrosis Type Ii and Intermediate Autosomal Recessive Osteopetrosis","volume":"19","author":"Li","year":"2019","journal-title":"Mol Med Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2017.1386529","article-title":"Novel Mutations of Clcn7 Cause Autosomal Dominant Osteopetrosis Type Ii (Adoii) and Intermediate Autosomal Recessive Osteopetrosis (Aro) in Seven Chinese Families","volume":"129","author":"Zhang","year":"2017","journal-title":"Postgrad Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-01127","article-title":"Diagnosis and Management of Osteopetrosis: Consensus Guidelines From the Osteopetrosis Working Group","volume":"102","author":"Wu","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1986","article-title":"Autosomal Dominant Osteopetrosis: Clinical Severity and Natural History of 94 Subjects With a Chloride Channel 7 Gene Mutation","volume":"92","author":"Waguespack","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780340502","article-title":"The American College of Rheumatology Criteria for the Classification and Reporting of Osteoarthritis of the Hip","volume":"34","author":"Altman","year":"1991","journal-title":"Arthritis Rheum"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780290816","article-title":"Development of Criteria for the Classification and Reporting of Osteoarthritis. Classification of Osteoarthritis of the Knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association","volume":"29","author":"Altman","year":"1986","journal-title":"Arthritis Rheum"},{"key":"B16","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1136\/ard.16.4.494","article-title":"Radiological Assessment of Osteo-Arthrosis","volume":"16","author":"Kellgren","year":"1957","journal-title":"Ann Rheum Dis"},{"key":"B17","article-title":"Differences in Male and Female Children and Adolescents of Acquisition With Bone Density in Changsha","volume":"12","author":"Wu","year":"2008","journal-title":"Chin J Osteoporos"},{"key":"B18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/s8756-3282(99)00244-6","article-title":"Type Ii Autosomal Dominant Osteopetrosis (Albers-Sch\u00f6nberg Disease): Clinical and Radiological Manifestations in 42 Patients","volume":"26","author":"B\u00e9nichou","year":"2000","journal-title":"Bone"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3715","article-title":"Interferon Gamma-1b Does Not Increase Markers of Bone Resorption in Autosomal Dominant Osteopetrosis","volume":"34","author":"Imel","year":"2019","journal-title":"J Bone Miner Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3109\/17453678909150106","article-title":"Fracture Patterns in Two Types of Autosomal-Dominant Osteopetrosis","volume":"60","author":"Bollerslev","year":"1989","journal-title":"Acta Orthop Scand"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2004.11.015","article-title":"Total Joint Arthroplasty in Patients With Osteopetrosis: A Report of 5 Cases and Review of the Literature","volume":"20","author":"Strickland","year":"2005","journal-title":"J Arthroplasty"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1979.02130090083017","article-title":"Visual Loss in Osteopetrosis","volume":"133","author":"Hoyt","year":"1979","journal-title":"Am J Dis Child"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/s0039-6257(99)00048-x","article-title":"Blindness From Bad Bones","volume":"43","author":"Siatkowski","year":"1999","journal-title":"Surv Ophthalmol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-Induced Exposed Bone (Osteonecrosis\/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and Treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2005.08.019","article-title":"Osteomyelitis of the Mandible Associated With Autosomal Dominant Osteopetrosis: A Case Report","volume":"102","author":"Albuquerque","year":"2006","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/bf00197140","article-title":"Benign Osteopetrosis: A Review of 42 Cases Showing Two Different Patterns","volume":"22","author":"el-Tawil","year":"1993","journal-title":"Skeletal Radiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s12663-015-0749-6","article-title":"Long-Term Follow-Up of Bimaxillary Osteomyelitis Associated With Autosomal Dominant Osteopetrosis: A Case Report","volume":"15","author":"Kulyapina","year":"2016","journal-title":"J Maxillofac Oral Surg"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1542\/peds.93.2.247","article-title":"Autosomal Recessive Osteopetrosis: Variability of Findings at Diagnosis and During the Natural Course","volume":"93","author":"Gerritsen","year":"1994","journal-title":"Pediatrics"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.1990.tb03578.x","article-title":"Autosomal Dominant Osteopetrosis Type Ii With \"Malignant\" Presentation: Further Support for Heterogeneity","volume":"38","author":"Walpole","year":"1990","journal-title":"Clin Genet"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/adc.24.118.143","article-title":"Osteopetrosis in Successive Generations","volume":"24","author":"Thomson","year":"1949","journal-title":"Arch Dis Child"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2715","article-title":"Bone Mineral Density and Microarchitecture in Patients With Autosomal Dominant Osteopetrosis: A Report of Two Cases","volume":"31","author":"Arruda","year":"2016","journal-title":"J Bone Miner Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket007","article-title":"Friend or Foe: High Bone Mineral Density on Routine Bone Density Scanning, a Review of Causes and Management","volume":"52","author":"Gregson","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00223-017-0332-x","article-title":"Clinical Significance of Dxa and Hr-Pqct in Autosomal Dominant Osteopetrosis (Ado Ii)","volume":"102","author":"Butscheidt","year":"2018","journal-title":"Calcif Tissue Int"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2003.18.8.1513","article-title":"Chloride Channel 7 (Clcn7) Gene Mutations and Autosomal Dominant Osteopetrosis, Type Ii","volume":"18","author":"Waguespack","year":"2003","journal-title":"J Bone Miner Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2003.18.10.1740","article-title":"Chloride Channel Clcn7 Mutations Are Responsible for Severe Recessive, Dominant, and Intermediate Osteopetrosis","volume":"18","author":"Frattini","year":"2003","journal-title":"J Bone Miner Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2012.12.072","article-title":"Rapid Gene Identification in a Chinese Osteopetrosis Family by Whole Exome Sequencing","volume":"516","author":"Sui","year":"2013","journal-title":"Gene"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.14.7633","article-title":"Transmembrane Topology of a Clc Chloride Channel","volume":"94","author":"Schmidt-Rose","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-015-3320-x","article-title":"Novel Mutations of Clcn7 Cause Autosomal Dominant Osteopetrosis Type Ii (Ado-Ii) and Intermediate Autosomal Recessive Osteopetrosis (Iaro) in Chinese Patients","volume":"27","author":"Pang","year":"2016","journal-title":"Osteoporos Int"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb4747","article-title":"Molecular Insights Into the Human Clc-7\/Ostm1 Transporter","volume":"6","author":"Zhang","year":"2020","journal-title":"Sci Adv"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.819641\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T13:19:23Z","timestamp":1647523163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.819641\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,17]]},"references-count":39,"alternative-id":["10.3389\/fendo.2022.819641"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.819641","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2022,3,17]]},"article-number":"819641"}}